Company Announcements

Directorate Change

Source: RNS
RNS Number : 1733U
Croda International PLC
24 March 2023

24 March 2023


Croda International Plc



Appointment of Non-Executive Director


The Board of Croda International Plc is pleased to announce the appointment of Chris Good as non-executive director. Chris will join the Board with effect from 27 April 2023.


Chris has spent his career in the consumer care industry.  He recently retired following more than 20 years at Estee Lauder Companies, a global leader in prestige beauty, with the last five years of his executive career as Group President of North America (Estee Lauder Companies' home market) with responsibility for over 25 brands. Chris was also a member of Estee Lauder Companies' Executive Committee.  


Prior to joining Estee Lauder Companies, Chris spent over 10 years at Unilever in senior marketing, executive and general management roles across Europe, North America and Asia.


On joining the Croda Board, Chris will also be appointed to the Audit, Nomination and Remuneration Committees. 


Anita Frew, Chair of Croda International Plc, said,


"I am delighted to welcome Chris to the Croda Board.


Chris' deep understanding of the consumer care industry and in particular his insights into beauty care markets and consumers will be of great value to Croda and the Board. As well as having significant P&L experience, Chris also brings a truly international perspective to the Board, having lived and worked in the USA, Switzerland, Japan, Singapore, Russia and the UK with region wide responsibilities for EMEA, APAC and North America during his successful executive career.


His appointment strengthens the consumer care knowledge and experience we have around the Board table, which will support our continued transition to a pure play Consumer Care and Life Sciences business."


There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.